ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Keyword Index

Click a keyword to view all the abstracts on this site tagged with that keyword.

  • Antiphospholipid antibodies and systemic sclerosis
  • antiphospholipid antibodies and thrombosis
  • antiphospholipid antibodies and transplantation
  • antiphospholipid syndrome
  • antiphospholipid syndrome and anticoagulation
  • antiphospholipid syndrome and Antiphospholipid Antibodies
  • antiphospholipid syndrome and autoantibodies
  • antiphospholipid syndrome and beta2 Glycoprotein I
  • Antiphospholipid syndrome and capillaroscopy
  • Antiphospholipid syndrome and catastrophic antiphospholipid syndrome
  • antiphospholipid syndrome and classification criteria
  • antiphospholipid syndrome and complement
  • antiphospholipid syndrome and fertility
  • Antiphospholipid syndrome and fibromyalgia
  • Antiphospholipid syndrome and genetics
  • antiphospholipid syndrome and genome
  • antiphospholipid syndrome and human leukocyte antigens (HLA)
  • antiphospholipid syndrome and infection
  • Antiphospholipid syndrome and innate immunity
  • antiphospholipid syndrome and interferons
  • antiphospholipid syndrome and laboratory tests
  • antiphospholipid syndrome and microbiome
  • Antiphospholipid syndrome and monoclonal antibodies
  • Antiphospholipid syndrome and monocytes
  • antiphospholipid syndrome and outcome measures
  • antiphospholipid syndrome and pediatric rheumatology
  • antiphospholipid syndrome and pregnancy
  • antiphospholipid syndrome and prognostic factors
  • antiphospholipid syndrome and registry
  • Antiphospholipid syndrome and renal disease
  • Antiphospholipid syndrome and risk assessment
  • antiphospholipid syndrome and SLE
  • antiphospholipid syndrome and statins
  • antiphospholipid syndrome and surgery
  • Antiphospholipid syndrome and systemic lupus erythematosus (SLE)
  • Antiphospholipid syndrome and thrombosis
  • Antirheumatic Agents
  • Antirheumatic Drugs Utilization
  • Anxiety
  • Anxiety and depression
  • anxiety and Disease Activity
  • Anxiety and fibromyalgia
  • aortitis
  • aphthous ulcers
  • APL
  • APL and antibodies
  • aPL and complement
  • APOL1
  • Apoptosis
  • apoptosis and cytokines
  • apoptosis and dendritic cells
  • Apoptosis and fibroblasts
  • apoptosis and heart block
  • apoptosis and inflammatory arthritis
  • apoptosis and interferons
  • Apoptosis and lupus nephritis
  • apoptosis and lymphocytes
  • apoptosis and lymphopenia
  • Apoptosis and mast cells
  • apoptosis and mesenchymal stem cells
  • apoptosis and monocytes
  • Apoptosis and rheumatoid arthritis (RA)
  • apoptotic clearance
  • apoptotic clearance and autoantibodies
  • app
  • appeals
  • appropriateness
  • appropriateness and osteoarthritis
  • apremilast
  • APRIL
  • aquaporin
  • AR882
  • Arrhythmia
  • Arteriosclerosis
  • arteriosclerosis and nephritis
  • arteriosclerosis and remission
  • arteriosclerosis and rheumatoid arthritis (RA)
  • arteriosclerosis and tumor necrosis factor (TNF)
  • arthralgia
  • arthralgia and polyreactvity
  • Arthritis
  • arthritis and anti-centromere antibodies (ACA)
  • arthritis and anti-citrullinated protein/peptide antibodies (ACPA)
  • arthritis and arthritis management
  • Arthritis and auto-immunity
  • arthritis and autoimmune diseases
  • arthritis and bacterial infections
  • arthritis and biomarkers
  • arthritis and bone density
  • Arthritis and bone disease
  • arthritis and bone remodeling
  • Arthritis and cancer treatments
  • arthritis and cartilage
  • arthritis and clinical research
  • arthritis and cognitive dysfunction
  • arthritis and cytokines
  • arthritis and Enthesitis
  • Arthritis and epidemiologic methods
  • Arthritis and fatigue
  • arthritis and fibroblasts
  • arthritis and functional status
  • arthritis and genetic disorders
  • arthritis and genomics
  • arthritis and health disparities
  • arthritis and hemochromatosis
  • Arthritis and infection
  • arthritis and inflammasome activation
  • arthritis and inflammation
  • arthritis and inflammatory arthritis
  • Arthritis and inflammatory bowel disease (IBD)
  • arthritis and injury
  • arthritis and kinase
  • arthritis and magnetic resonance imaging (MRI)
  • Arthritis and major histocompatibility complex (MHC)
  • arthritis and memory
  • arthritis and microbiome
  • Arthritis and microparticles
  • Arthritis and mouse model
  • arthritis and musculoskeletal sonography
  • arthritis and myositis
  • arthritis and neuropathy
  • Arthritis and neutropenia
  • arthritis and neutrophils
  • Arthritis and opioids
  • arthritis and osteoclastogenesis
  • arthritis and osteoclasts
  • arthritis and osteoporosis
  • Arthritis and outcomes
  • Arthritis and pain
  • arthritis and pediatrics
  • Arthritis and polymyalgia rheumatica
  • arthritis and population studies
  • arthritis and psoriatic arthritis
  • Arthritis and quality of life
  • arthritis and severity
  • arthritis and sex hormones
  • Arthritis and systemic sclerosis
  • arthritis and thyroid
  • arthritis and tolerance
  • arthritis and treatment
  • arthritis and ultrasonography
  • Arthritis and ultrasound
  • arthritis and utilization review
  • arthritis and uveitis
  • arthritis and viruses
  • arthritis management
  • arthritis management and biologic response modifiers
  • arthritis management and cancer treatments
  • arthritis management and cell therapy
  • arthritis management and community programs
  • arthritis management and education
  • Arthritis management and infection
  • arthritis management and inflammation
  • Arthritis management and medication
  • arthritis management and mouse model
  • arthritis management and pregnancy
  • Arthritis management and rheumatoid arthritis (RA)
  • arthritis management and synovial cells
  • arthritis management and ultrasonography
  • Arthritis, Infectious
  • Arthrocentesis
  • arthrocentesis and inflammation
  • Arthrocentesis and juvenile arthritis
  • Arthrocentesis and quality improvement
  • Arthrocentesis and utilization review
  • Arthropathy
  • Arthroplasty
  • arthroplasty and disability
  • arthroplasty and exercise
  • arthroplasty and infection
  • arthroplasty and obesity
  • Arthroplasty and osteoarthritis
  • arthroplasty and outcomes
  • Arthroplasty and pain management
  • arthroplasty and patient engagement
  • arthroplasty and questionnaires
  • Arthroplasty and rheumatoid arthritis (RA)
  • arthroplasty and social support
  • Arthroplasty and systemic lupus erythematosus (SLE)
  • arthroplasty and weight loss
  • Arthroscopy
  • Arthroscopy and infection
  • arthroscopy and ultrasound
  • AS
  • ASAH1
  • asas
  • ASCVD
  • ascvd score and bsdmard therapy
  • Asian-Americans
  • Aspergillus and rheumatologic disease
  • aspirin
  • Aspirin and inflammation
  • aspirin and outcome measures
  • Assessment
  • Assessment and body image
  • Assessment and fatigue
  • assessment and fibromyalgia
  • assessment and outcomes
  • Assessment and pain
  • assessment and patient engagement
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • [5]
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »
  • | Last
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology